University of Salamanca, Spain, hematologist Maria-Victoria Mateos presenting the data from J&J's MajesTEC-3 trial in a press conference at the 2025 American Society of Hematology meeting. (Alaric DeArment)
Keep up with the top pharma business news of the week. On the go.
